Davis Quoted on Court Ruling Bolstering New Type of 'Poison Pill'
May 7, 2014
Wall Street Journal
Partner Gardner Davis was quoted in a Wall Street Journal article published on May 7, 2014, titled “Court Ruling Bolsters New Type of ‘Poison Pill.’” The article discussed a recent decision made by the Delaware Court of Chancery that affirmed the legality of a new type of “poison pill,” a tactic used by a company threatened with an unwelcome takeover bid to make itself unattractive to the bidder. This new arrangement has found favor among companies seeking protection from activist investors. Davis was quoted saying, “If I’m the general counsel of a public company and I’m worried about an activist investor—and these days, everybody is worried—this is…a nice tool to have on the shelf.”
People
Related News
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."
August 1, 2025
In the News
Aaron Maguregui Assesses HIPAA Challenges as AI Advances in Health Care
Foley & Lardner LLP partner Aaron Maguregui commented in the Medical Device Network article, "AI proliferation in healthcare shines light on HIPAA shortcomings," assessing the rise and accompanying risks of artificial intelligence in health care.
August 1, 2025
In the News
Louis Lehot Assesses Figma IPO
Foley & Lardner LLP partner Louis Lehot commented on a major technology initial public offering in the Business Insider article, "Lina Kahn is taking a victory lap over the Figma IPO."